Soluble PD-1 (programmed death-1) molecule with high affinity

A PD-1, PDL-1 technology, applied in the biological field, can solve the problems of tumor immune escape and weaken anti-tumor immune response

Inactive Publication Date: 2018-05-04
GUANGDONG XIANGXUE LIFE SCI LTD
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many tumor cell lines and tumor cells highly express PDL-1 molecule (Konishi J et al., Clin. Cancer Res., 2004, 10(15):5094-5100), after it binds to the PD-1 molecule on the surface of lymphocytes , which weakens the body's anti-tumor immune response (Radziewicz H et al., J Virol, 2007, 81(6):2545-2553), leading to the occurrence of tumor immune escape

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Soluble PD-1 (programmed death-1) molecule with high affinity
  • Soluble PD-1 (programmed death-1) molecule with high affinity
  • Soluble PD-1 (programmed death-1) molecule with high affinity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0141] Example 1 Expression, renaturation and purification of wild-type PD-1

[0142] The extracellular amino acid sequence and nucleotide sequence of wild-type PD-1 are SEQ ID NO.1 and 2, respectively, and the target gene carrying the extracellular sequence of wild-type PD-1 is double-digested with Nco I and Not I, and combined with The pET28a vector (Novagen) that has been digested with Nco Ⅰ and Not Ⅰ double enzymes (this vector has been optimized and has a biotin tag) is ligated. The ligation product was transformed into E.coli DH5α (Vazyme), coated with kanamycin-containing LB plate, cultured upside down at 37°C overnight, picked positive clones for PCR screening, sequenced the positive recombinants, and extracted after confirming the correct sequence The recombinant plasmid was transformed into E.coli Rosetta strain (TIANGEN) for expression.

[0143] Inoculate the above-mentioned Rosetta colony containing the recombinant plasmid pET28a-PD-1 in LB medium containing kanam...

Embodiment 2

[0145] Example 2 Combination Characterization

[0146] BIAcore analysis

[0147] The BIAcore T200 real-time analysis system was used to detect the binding activity of wild-type PD-1 molecules to PDL-1. Add the anti-streptavidin antibody (GenScript) to the coupling buffer (10mM sodium acetate buffer, pH 4.77), and then flow the antibody through the CM5 chip activated with EDC and NHS to immobilize the antibody on the chip surface , and finally the unreacted activated surface was blocked with ethanolamine hydrochloric acid solution to complete the coupling process, and the coupling level was about 15,000 RU.

[0148] Let a low concentration of streptavidin flow over the surface of the antibody-coated chip, then flow biotinylated PD-1 through the detection channel, and the other channel as a reference channel, and then add 0.05mM biotin in 10μL / min flow through the chip for 2 minutes to block the remaining binding sites of streptavidin. The affinity was determined by a single...

Embodiment 3

[0155] Example 3 Production of High Affinity PD-1 Molecules

[0156] Using the extracellular sequence of wild-type PD-1 described in Example 1 as a template strand, according to the phage display and screening method described in Li et al. (2005) NatureBiotech 23 (3): 349-354), high-affinity PD-1 1 screening. After several rounds of screening, the phage library had a strong binding signal to PD-1, and a single clone was picked from it for sequence analysis.

[0157] Express, refold and purify the high-affinity PD-1 molecule of the present invention according to the method described in Example 1, and determine its affinity with PDL-1 molecule according to the method described in Example 2. The affinity between the high-affinity PD-1 molecule obtained in the present invention and the PDL-1 molecule is at least 2 times that of the wild-type PD-1 molecule and the PDL-1 molecule, and its amino acid sequence and its affinity value with the PDL-1 molecule are as follows Table 1 sho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a soluble PD-1 (programmed death-1) molecule with high affinity, and particularly provides a PD-1 molecule. The PD-1 molecule is mutated on the basis of a wild PD-1 molecule, and affinity of the PD-1 molecule and a PDL-1 (Programmed Death Ligand-1) molecule is at least twice that of the wild PD-1 molecule and a wild PDL-1 molecule. Meanwhile, the PD-1 molecule can effectively improve the killing capacity of lymphocytes. Besides, the invention provides nucleic acid encoding the PD-1 molecule and a PD-1 molecule complex. The PD-1 molecule can be used alone or in combination with other molecules.

Description

technical field [0001] The present invention relates to the field of biotechnology, more specifically to high-affinity soluble programmed death receptor (Programmed Death-1, PD-1) molecules that can recognize programmed death receptor ligand PDL-1 (Programmed Death-1) with high affinity Ligand-1, PDL-1) molecules. The present invention relates to the preparation method and use of this molecule. Background technique [0002] PD-1 is an immunosuppressive receptor expressed on activated T cells and B cells, and its ligand is PDL-1 or PDL-2. PD-1 belongs to the B7 family and is an Ig superfamily type I transmembrane glycoprotein with a size of 50-55kD; it consists of three parts: the extracellular IgV region, the transmembrane region and the intracellular region. Membrane-proximal cysteine ​​residues, PD-1 exist as monomers (Xuewu Zhang and Almo, Immunity, 2004, 20, 337–347). PD-1 interacts with the ligand PDL-1 and plays an important role in the negative regulation of the im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/705C07K19/00C12N15/12C12N15/62A61K38/17A61P35/00
CPCC07K14/70521A61K38/00C07K2319/00A61K38/17A61P35/00C07K14/705C07K19/00C12N15/62
Inventor 李懿李艳艳
Owner GUANGDONG XIANGXUE LIFE SCI LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap